2,6,10-Trimethyl-2,6,9,11-dodecatetraene

Details

Top
Internal ID 583f354b-d596-4c3f-a352-70aae7e0e617
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name 3,7,11-trimethyldodeca-1,3,6,10-tetraene
SMILES (Canonical) CC(=CCCC(=CCC=C(C)C=C)C)C
SMILES (Isomeric) CC(=CCCC(=CCC=C(C)C=C)C)C
InChI InChI=1S/C15H24/c1-6-14(4)10-8-12-15(5)11-7-9-13(2)3/h6,9-10,12H,1,7-8,11H2,2-5H3
InChI Key CXENHBSYCFFKJS-UHFFFAOYSA-N
Popularity 151 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 6.10
Atomic LogP (AlogP) 5.20
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 6

Synonyms

Top
3,7,11-trimethyldodeca-1,3,6,10-tetraene
2,6,10-Trimethyl-2,6,9,11-dodecatetraene
DTXSID1047235
FT-0604961
FT-0606534
2,6,10-trimethyl 2,6,9,11-dodecatetraene
Q27119779
125037-13-0

2D Structure

Top
2D Structure of 2,6,10-Trimethyl-2,6,9,11-dodecatetraene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9860 98.60%
Caco-2 + 0.9292 92.92%
Blood Brain Barrier + 1.0000 100.00%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Nucleus 0.6326 63.26%
OATP2B1 inhibitior - 0.8578 85.78%
OATP1B1 inhibitior + 0.9239 92.39%
OATP1B3 inhibitior + 0.9322 93.22%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8000 80.00%
BSEP inhibitior - 0.7881 78.81%
P-glycoprotein inhibitior - 0.9689 96.89%
P-glycoprotein substrate - 0.9580 95.80%
CYP3A4 substrate - 0.6281 62.81%
CYP2C9 substrate - 0.8209 82.09%
CYP2D6 substrate - 0.7550 75.50%
CYP3A4 inhibition - 0.9627 96.27%
CYP2C9 inhibition - 0.8903 89.03%
CYP2C19 inhibition - 0.8891 88.91%
CYP2D6 inhibition - 0.9474 94.74%
CYP1A2 inhibition - 0.7161 71.61%
CYP2C8 inhibition - 0.9661 96.61%
CYP inhibitory promiscuity - 0.7252 72.52%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.5600 56.00%
Carcinogenicity (trinary) Warning 0.4862 48.62%
Eye corrosion + 0.7167 71.67%
Eye irritation + 0.9582 95.82%
Skin irritation + 0.8426 84.26%
Skin corrosion - 0.9833 98.33%
Ames mutagenesis - 0.8300 83.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4242 42.42%
Micronuclear - 1.0000 100.00%
Hepatotoxicity - 0.5552 55.52%
skin sensitisation + 0.9235 92.35%
Respiratory toxicity - 0.7778 77.78%
Reproductive toxicity - 0.9778 97.78%
Mitochondrial toxicity - 0.6750 67.50%
Nephrotoxicity - 0.5797 57.97%
Acute Oral Toxicity (c) III 0.9077 90.77%
Estrogen receptor binding - 0.8763 87.63%
Androgen receptor binding - 0.8494 84.94%
Thyroid receptor binding - 0.7943 79.43%
Glucocorticoid receptor binding + 0.5645 56.45%
Aromatase binding - 0.6435 64.35%
PPAR gamma + 0.7506 75.06%
Honey bee toxicity - 0.8851 88.51%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity + 0.9962 99.62%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 89.96% 98.95%
CHEMBL3401 O75469 Pregnane X receptor 88.83% 94.73%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.88% 96.09%
CHEMBL4769 O95749 Geranylgeranyl pyrophosphate synthetase 85.41% 92.08%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.36% 91.11%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 80.37% 93.10%

Cross-Links

Top
PubChem 442368
NPASS NPC5172
LOTUS LTS0276082
wikiData Q27119779